RESEARCH TRIANGLE PARK, N.C. - CeNeRx BioPharma, Inc., a start up biopharmaceutical company focused on developing new therapeutics for disorders of the central nervous system, today announced the completion of $18.5 million in series A financing.
CeNeRx BioPharma (CeNeRx) is dedicated to acquiring and developing early- stage compounds for…
LINCOLN, R.I. - For the fifth consecutive year, PharmaCare has achieved the top ranking for “overall service and performance” — in the 2005 Customer Satisfaction Report conducted by the Pharmacy Benefit Management Institute (PBMI).* PharmaCare, the fourth largest non-payor based PBM in the nation, is a wholly-owned subsidiary of CVS…
BERKELEY, Calif. - Vivacare today announced its corporate launch and introduced Internet-based tools for physicians designed to improve patient knowledge and medication compliance. The company creates and manages online, customized “Patient Care Center” sites, which deliver educational services and compliance-enhancing messages to patients from the source they trust most, their…
FARMINGTON, Conn. - DrugMax, Inc. (NASDAQ:DMAX) , a specialty pharmacy and drug distribution provider, today announced that its Board of Directors has appointed the Company’s Chief Executive Officer, Ed Mercadante, as Chairman of the Board. The Company also announced that Jugal K. Taneja, has retired from his position as Co-Chairman,…
FORT WASHINGTON, Pa. - Vitae Pharmaceuticals, Inc. announced today that it has initiated Phase II clinical studies with VTP- 201227 for the treatment of psoriasis and VTP-195183 to enhance immune cell levels in specific cancer treatments.
“Within the last 18 months, Vitae has progressed multiple products into Phase II…
SOUTH SAN FRANCISCO, Calif. - OTN (Oncology Therapeutics Network), a leading independent oncology services company, and Onmark, its group purchasing organization (GPO), today announced that Southern Oncology Association of Practices (SOAP) has awarded its $350 million oncology services business to OTN and Onmark. The award by SOAP, which represents more…
NEW YORK - Among the 89.4 million U.S. adults seeking additional information after seeing or hearing direct-to-consumer (DTC) drug ads, more consumers report that they go online for information than dial the 800 number. In fact, more than 22 million consumers now report going online to learn more about the…
NEW YORK - Among the 89.4 million U.S. adults seeking additional information after seeing or hearing direct-to-consumer (DTC) drug ads, more consumers report that they go online for information than dial the 800 number. In fact, more than 22 million consumers now report going online to learn more about the…
PITTSBURGH - Mylan Laboratories Inc. (NYSE:MYL) today announced that Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Glimepiride Tablets, 1 mg, 2 mg, and 4 mg. Glimepiride Tablets are the AB-rated generic equivalent of Aventis…
WALTHAM, Mass. - Decision Resources, Inc., one of the world’s leading research and advisory firms focusing on pharmaceutical and health care issues, finds that the market for vascular endothelial growth factor (VEGF) inhibitors for the treatment of various forms of cancer will experience a nearly ten-fold increase, growing from $550…